98 related articles for article (PubMed ID: 22649896)
1. Development of Graves' disease following radioiodine treatment for autonomously functioning thyroid adenoma: case report.
Martinko J; Cigrovski-Berković M; Becejac B; Solter D; Solter M
Acta Clin Croat; 2011 Dec; 50(4):615-7. PubMed ID: 22649896
[TBL] [Abstract][Full Text] [Related]
2. Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma.
Regalbuto C; Salamone S; Scollo C; Vigneri R; Pezzino V
J Endocrinol Invest; 1999 Feb; 22(2):147-50. PubMed ID: 10195384
[TBL] [Abstract][Full Text] [Related]
3. Graves' disease triggered by autoinfarction of an autonomously functioning thyroid adenoma.
Gallegos E; Meier DA; Garcia M
J Nucl Med; 1997 Feb; 38(2):260-2. PubMed ID: 9025752
[TBL] [Abstract][Full Text] [Related]
4. [Radioiodine therapy of autonomously functioning thyroid nodules and Graves' disease].
Guhlmann CA; Rendl J; Börner W
Nuklearmedizin; 1995 Feb; 34(1):20-3. PubMed ID: 7724360
[TBL] [Abstract][Full Text] [Related]
5. Results of radioiodine (131/125I) therapy of hyperthyroidism.
Glanzmann C; Horst W; Magdeburg W
Radiol Clin (Basel); 1975; 44(5):484-90. PubMed ID: 1208842
[TBL] [Abstract][Full Text] [Related]
6. Thyroid remnant radioiodine ablation in a case of concurrent thyroid carcinoma, Graves' disease, and thyroid ophthalmopathy.
Mansberg R
Clin Nucl Med; 2007 Jul; 32(7):513-5. PubMed ID: 17581332
[TBL] [Abstract][Full Text] [Related]
7. Graves' ophthalmopathy and 131I therapy.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous transition of an autonomously functioning thyroid adenoma to Graves' disease.
Bommireddipalli S; Gadiraju R; DePuey GE
Clin Nucl Med; 2009 Dec; 34(12):845-7. PubMed ID: 20139814
[TBL] [Abstract][Full Text] [Related]
9. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
10. [Hypothyroidism caused by radioiodine therapy].
Miclulţia M; Derevenco V; Holan T
Stud Cercet Endocrinol; 1972; 23(4):263-9. PubMed ID: 4681800
[No Abstract] [Full Text] [Related]
11. [Development of Basedow disease after radioiodine therapy for nodular goiter].
Cseke B; Balázs C
Orv Hetil; 2003 Nov; 144(47):2327-9. PubMed ID: 14725052
[TBL] [Abstract][Full Text] [Related]
12. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
Jukić T; Stanicić J; Petric V; Kusić Z
Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
[TBL] [Abstract][Full Text] [Related]
13. Thyroid cancer prevalence after radioiodine treatment of hyperthyroidism.
Angusti T; Codegone A; Pellerito R; Favero A
J Nucl Med; 2000 Jun; 41(6):1006-9. PubMed ID: 10855625
[TBL] [Abstract][Full Text] [Related]
14. [Paradoxical effect of radioiodine therapy in functional thyroid autonomy and mild immunothyropathy].
Dunkelmann S; Rudolph F; Prillwitz A; Groth P; Schümichen C
Nuklearmedizin; 1998 Jan; 37(1):23-9. PubMed ID: 9467166
[TBL] [Abstract][Full Text] [Related]
15. Vitamin B12 levels are not affected by radioiodine ablation of the thyroid.
Potham SK; Vaikkakara S; Sachan A; Rao SP; Kalawat TC; Ravi P; Sunil E; Rajitha D; Arun M; Sailaja A
Endocr Regul; 2014 Apr; 48(2):77-85. PubMed ID: 24824803
[TBL] [Abstract][Full Text] [Related]
16. [Graves' disease nd toxic nodular goiter--radioiodine therapy].
Schicha H; Dietlein M
Nuklearmedizin; 2002 Apr; 41(2):63-70. PubMed ID: 11989300
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
18. Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?
Kobe C; Eschner W; Wild M; Rahlff I; Sudbrock F; Schmidt M; Dietlein M; Schicha H
Nucl Med Commun; 2010 Mar; 31(3):201-5. PubMed ID: 19907353
[TBL] [Abstract][Full Text] [Related]
19. Appearance of Graves'-like disease following regression of autonomously functioning thyroid nodules. Two case reports.
Orsolon P; Lupi A; De Antoni Migliorati G; Vianello Dri A
Minerva Endocrinol; 1998 Jun; 23(2):53-6. PubMed ID: 9844355
[TBL] [Abstract][Full Text] [Related]
20. An autonomously functioning thyroid carcinoma associated with euthyroid Graves' disease.
Michigishi T; Mizukami Y; Shuke N; Satake R; Noguchi M; Aburano T; Tonami N; Hisada K
J Nucl Med; 1992 Nov; 33(11):2024-6. PubMed ID: 1432166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
